Van Laer Lut, Meyer Nicole C, Malekpour Mahdi, Riazalhosseini Yasser, Moghannibashi Mahdi, Kahrizi Kimia, Vandevelde Ann, Alasti Fatemeh, Najmabadi Hossein, Van Camp Guy, Smith Richard J H
Department of Medical Genetics, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, B-2610, Antwerp, Belgium.
Molecular Otolaryngology Research Laboratories, University of Iowa, Iowa City, IA, USA.
J Hum Genet. 2007;52(6):549-552. doi: 10.1007/s10038-007-0137-2. Epub 2007 Apr 11.
Mutations in DFNA5 lead to autosomal dominant non-syndromic sensorineural hearing loss that starts at the high frequencies. To date, only three DFNA5 mutations have been described, and although different at the genomic DNA level, all lead to exon 8 skipping at the mRNA level. This remarkable fact has led towards the hypothesis that DFNA5-associated hearing loss is caused by a gain-of-function mutation and not by haplo-insufficiency as previously thought. Here, we describe a fourth DFNA5 mutation: the insertion of a cytosine at nucleotide position 640 (AF073308.1:_c.640insC, AAC69324.1:_p. Thr215HisfsX8). Unlike the previously described mutations, this frameshift mutation truncates the protein in exon 5 of the gene. Although the mutation was found in an extended Iranian family with hereditary hearing loss, it does not segregate with the hearing loss phenotype and is even present in persons with normal hearing. This fact provides further support for the hypothesis that DFNA5-associated hearing loss is caused by a gain-of-function mutation.
DFNA5基因突变会导致常染色体显性非综合征性感音神经性听力损失,始于高频。迄今为止,仅描述了三种DFNA5基因突变,尽管在基因组DNA水平上有所不同,但在mRNA水平上均导致外显子8跳跃。这一显著事实引发了一种假说,即DFNA5相关的听力损失是由功能获得性突变引起的,而非如之前所认为的单倍体不足。在此,我们描述了第四种DFNA5基因突变:在核苷酸位置640处插入一个胞嘧啶(AF073308.1:_c.640insC,AAC69324.1:_p. Thr215HisfsX8)。与之前描述的突变不同,这种移码突变使该基因外显子5中的蛋白质截短。尽管该突变是在一个患有遗传性听力损失的伊朗大家庭中发现的,但它与听力损失表型并不分离,甚至在听力正常的人身上也存在。这一事实为DFNA5相关听力损失是由功能获得性突变引起的假说提供了进一步支持。